Atlas Trials

Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant

Clinical trial NCT04932564 · TERMINATED

Trial details

NCT number
NCT04932564
Sponsor
Tata Memorial Centre
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Musculoskeletal Disease OtherGVHD, Chronic
Start date
2023-09-18
Primary completion
2024-06-25
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.